Telomeres and telomerase in normal and malignant haematologic cells

Leukemia and Lymphoma

Volumn 24, Issue 1-2, 1996, Pages 1-9

  Leber, Brian ^a   Bacchetti, Silvia ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Leukemia; Telomerase; Telomeres

Indexed keywords

ANTINEOPLASTIC AGENT; REPETITIVE DNA; RETINOIC ACID; TELOMERASE; ZIDOVUDINE;

BLOOD CELL; BONE MARROW CELL; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TELOMERE;

BONE MARROW; HEMATOLOGIC NEOPLASMS; HUMANS; PROGNOSIS; REFERENCE VALUES; TELOMERASE; TELOMERE; TUMOR MARKERS, BIOLOGICAL;

EID: 0030453866     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199609045709     Document Type: Article

References (58)

1. Zakian, V. A. (1995) Telomeres: beginning to understand the end. Science, 270, 1601-1607.
2. Fang, G. and Cech, T R. (1995) Telomere proteins. In: Blackburn, E. H. and Greider, C. W. (eds). Telomeres, pp. 69-105, Cold Spring Harbor Laboratory, Cold Spring Harbor.
3. Olovnikov, A. M. (1971). Principle of marginotomy in template synthesis of polynucleotides. Doklady Biochemistry, 201, 394-397.
4. Watson, J. D. (1972). Origins of concatemeric T7 DNA, Nature New Biology, 239, 197-201.
5. Greider, C. W. and Blackburn, E. H. (1985). Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell, 43, 405-413.
6. Greider, C. W and Blackburn, E. H. (1989). A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature, 337, 331-337.
7. Collins, K., Kobayashy, R. and Greider, C W. (1995). Purification of Tetrahymena telomerase and cloning of genes encoding the two protein components of the enzyme. Cell. 81, 677-686.
8. Olovnikov, A. M (1973). A theory of marginotomy: the incomplete copying of template margin in enzymatic synthesis of polynucleotides and biological significance of the phenomenon. Journal of Theoretical Biology, 41, 181-190.
9. Harley, C. B. (1991). Telomere loss: mitotic clock or genetic bomb? Mutation Research, 256, 271-282
10. Counter, C. M., Avilion, A. A., LeFeuvre, C. E., Stewart, N G., Greider, C W , Harley, C. B and Bacchetti, S. (1992). Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. The EMBO Journal, 11, 1921-1929
11. Counter, C. M., Botelho, F. M , Wang, P., Harley, C. B. and Bacchetti, S. (1994). Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. Journal of Virology, 68, 3410-3414.
12. Klingelhutz, A. J., Barber, S. A., Smith, P. P., Dyer, K. and McDougall, J K. (1994). Restoration of telomeres in human Papillomavirus-immortalized human anogenital epithelial cells. Mol. Cell. Biol., 14, 961-969.
13. Shay, J W., Tomlinson, G., Piatyszek, M. A. and Gollahon, L. S. (1995). Spontaneous in vitro immortalization of breast epithelial cells from a patient with Li-Fraumeni syndrome. Mol Cell. Biol , 15, 423-432.
14. Harley, C. B., Futcher, A. B. and Greider, C. W. (1990). Telomeres shorten during ageing of human fibroblasts. Nature, 345, 458-460.
15. Allsopp, R. C., Vazin, H., Patterson, C., Goldstein, S., Younglai, E. V., Futcher, A. B., Greider, C. W. and Harley, C. B. (1992). Telomere length predicts replicative capacity of human fibroblasts. Proceedings of the National Academy of Sciences USA, 89, 10114-10118.
16. Feng, J., Funk, W. D., Wang, S.-S., Weinrich, S. L., Avilion, A. A., Chiu, C.-P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., Le, S., West, M. D., Harley, C. B., Andrews, W. H., Greider, C. W. and Villeponteau, B. (1995). The RNA component of human telomerase, Science, 269, 1236-1241.
17. Ohmura, H., Tahara, H., Suzuki, M., Ide, T., Shimizu, M., Yoshida, M. A., Tahara, E., Shay, J. W., Barrett, J. C. and Oshimura, M. (1995). Restoration of the cellular senecence program and repression of telomerase by human chromosome 3, Japanese Journal of Cancer. 86, 899-904.
18. Wright, E. W . Brašiškyté, D., Piatyszek, M. A and Shay, J. W. (1996) Experimental elongation of telomeres extends the lifespan of immortal x normal cell hybrids. The EMBO Journal. 15, 1734-1741.
19. Bacchetti, S. and Counter, C M. (1995). Telomeres and telomerase in human cancer. International Journal of Oncology, 7, 423-432.
20. Counter, C. M., Hirte, H. W., Bacchetti, S. and Harley, C. B. (1994). Telomerase activity in human ovarian carcinoma. Proceedings of the National Academy of Sciences USA, 91, 2900-2904.
21. Allshire, R C., Gosden, J. R., Cross, S H , Cranston, G , Rout, D., Sugawara, N., Szostak, J. W , Fantes, P. A. and Hastie, N. D. (1988). Telomeric repeat from T. termophila cross-hybridizes with human telomeres. Nature, 332, 656-659.
22. Allshire, R. C. Dempster, M. and Hastie, N. D. (1989). Human telomeres contain at least three types of G-rich repeats distributed non-randomly. Nucleic Acids Research, 17, 4611-4627.
23. Brown, W. R A., MacKinnon, P. J., Villasanté, A., Spurr, N., Buckle, V. J and Dobson, M. J. (1990) Structure and polymorphism of human telomere-associated DNA, Cell, 63, 119-132.
24. de Lange, T., Shiue, L., Myers, R M., Cox, D. R., Naylor, S. L., Killery, A. M. and Varmus, H E (1990). Structure and variability of human chromosome ends, Molecular and Cellular Biology, 10, 518-527.
25. Levy, M. Z., Allsopp, R. C., Futcher, A. B., Greider, C W. and Harley, C. B. (1992). Telomere end-replication problem and cell aging. Journal of Molecular Biology, 225, 951-960.
26. Morin, G B (1989). The human telomere terminal transferase enzyme is a riboprotein that synthesizes TTAGGG repeats,Cell. 59, 521-529
27. Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W E., Weinrich, S. L. and Shay, J. L. (1994) Specific association of human telomerase activity with immortal cells and cancer. Science, 266, 2011-2015
28. Wright, E. W., Shay, J. W. and Piatyszek, M. A. (1995). Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity.Nucleic Acids Research, 23, 3794-3795.
29. Avilion, A. A., Piatyszek, M. A., Gupta, J., Shay, J. W., Bacchetti, S. and Greider, C. W (1966). Human telomerase RNA and telomerase activity in immortal cell lines and tissues. Cancer Research, 56, 645-650.
30. Blasco, M. A., Rizen, M., Greider, C. W. and Hanahan, D. (1996). Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis, Nature Genetics, 12, 200-204.
31. Broccoli, D., Godley, L. A., Donehower, L. A., Varmus, H. E. and de Lange, T. (1996). Telomerase activation in mouse mammary tumors: lack of detectable telomere shortening and evidence for regulation of telomerase RNA with cell proliferation. Molecular and Cellular Biology, 16, 3765-3777
32. Vaziri, H., Schächter, F., Uchida, I , Wei, L., Zhu, X , Effros, R., Cohen, D. and Harley, C. B. (1993). Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am. J. Hum. Genet., 52, 661-667.
33. Schmitt, H., Blin, N., Zankl, H. and Schertan H (1994). Telomere length variation in normal and malignant tissues, Genes Chromosomes Cancer, 11, 171-177.
34. Vaziri, H., Dragowska, W., Allsop, R. C., Thomas, T. E., Harley, C. B. and Landsdorp, P. M. (1994). Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age, Proc. Natl. Acad Sci. USA, 91, 9857-9860.
35. Yamada, O., Oshimi, K. and Mizoguchi, H. (1993). Telomere reduction in hematologic cells. Int. J. Hematol, 57, 185-186.
36. Yamada, O., Oshimi, K., Motoji, T. and Mizoguchi, H. (1995). Telomeric DNA in normal and leukemic blood cells, J. Clin. Invest., 95, 1117-1123.
37. Adamson, D. J. A , King, D. J. and Haites, N. E. (1992). Significant telomere shortening in childhood leukemia. Cancer Genet Cytogenet, 61, 204-206.
38. Nilsson, P., Mehle, C., Remes, K. and Roos G. (1994). Telomerase activity in human malignant hematopoietic cells. Oncogene, 9, 3043-3048.
39. Counter, C. M , Gupta, J , Harley, C. B., Leber, B. and Bacchetti, S. (1995). Telomerase activity in normal leukocytes and in hematologic malignancies, Blood, 85, 2315-2320.
40. Ohyashiki, J. H., Ohyashiki, K., Fujimura, T , Kawakubo, K., Shimamoto, T., Iwabuchi, A. and Toyama, K. (1994). Telomere shortening associated with disease evolution patterns in myelodysplasic syndromes. Cancer Res., 54, 3557-3560.
41. Ohyashiki, K., Ohyashiki, J. H., Fujimura, T , Kawakubo, K , Shimamoto, T., Saito, M , Nakazawa, S. and Toyama, K. (1994). Telomere shortening in leukemic cells is related to their genetic alterations but not replicative capacity, Cancer Genet Cytogenet, 78, 64-47.
42. Takauchi, K., Tashiro, S . Ohtaki, M. and Kamada N. (1994). Telomere reduction of specific chromosome translocation in acute myelocytic leukemia, Jpn. J. Cancer Res., 85, 127-130.
43. Hastie, N. D., Dempster, M., Dunlop, M. G., Thompson, A. M , Green, D. K and Allshire, R C. (1990). Telomere reduction in human colorectal carcinoma and with ageing. Nature, 346, 886-871.
44. Broccoli, D., Young, J. W. and de Lange, T. (1995). Telomerase activity in normal and malignant hematopoietic cells, Proc. Natl. Acad. Sci. USA. 92, 9082-9086.
45. Hiyama, K., Hirai, Y., Kyoizumi, S., Akiyama, M., Hiyama, E., Piatyszek, M. A., Shay, J. W., Ishioka, S and Yamakido, M. (1995). Activation of telomerase in human lymphocytes and hematopoietic progenitors, J. Immunol., 15, 3711-3715.
46. Chiu, C-P, Dragowska, W., Kim, N. W., Vaziri, H., Yui, J., Thomas, T. E., Harley, C. B. and Lansdorp, P. M. (1996). Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow. Stem Cell. 14, 239-248.
47. Lansdorp, P. M., Verwoerd, N. P., van de Rijke, F. M., Dragowska, V., Little, M-T., Dirks, R. W., Raap, A. K. and Tanke, H. J. (1996). Heterogeneity in telomere length of human chromosomes. Human Mol. Genet., 5, 685-691.
48. Zhang, W., Piatyszek, M. A., Kobayashi, T., Estey, E., Andreeff, M., Deisseroth, A. B., Wright, W. E. and Shay, J. W. (1996). Telomerase activity in human acute myelogenous leukemia, inhibition of telomerase activity by differentiation-inducing agents, Clin. Cancer Res., 2, 799-803.
49. Hiyama, E., Hiyama, K., Yokoyama, T., Matsura, Y , Piatyszek, M. A. and Shay J. W. (1995). Correlating telomerase activity levels with human neuroblastoma outcomes. Nature Med., 1, 249-255.
50. Sharma, H. W., Sokoloski, J. A., Perez, J. R., Maltese, J. Y., Sartorelli, A. C., Stein, C. A., Nichols, G., Khaled, Z., Telang, N. T. and Narayanan, R. (1995). Differentiation of immortal cells inhibits telomerase activity, Proceedings of the National Academy of Sciences USA, 92, 12343-12346.
51. Holt S. E , Wright, W. E. and Shay, J. W. (1996). Regulation of telomerase activity in immortal cell lines. Molecular and Cellular Biology, 16, 2932-2939.
52. Langford, L. A., Piatyszek, M. A., Xu, R., Schold, S. C. and Shay J W. (1995). Telomerase activity in human brain tumours, Lancet, 346, 1267-1268.
53. Gupta, J , Han, L. P., Wang, P., Gallie, B. L. and Bacchetti, S. (1996). Development of retinoblasloma in the absence of telomerase activity, J. Natl. Cancer Inst., 88, 1152-1157
54. Brodeur, G M. (1995). Do the ends justify the means? Nature Med., 1, 203-205.
55. Morin, G. B. (1995). Is telomerase a universal cancer target? J. Natl. Cancer Inst., 87, 859-861.
56. Strahl, C. and Blackburn, E. H. (1996). Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines. Mol. Cell Biol., 16, 53-65.
57. Bryan, T. M , Englezou, A., Gupta, J., Bacchetti, S. and Reddel, R R. (1995). Telomere elongation in immortal human cells without detectable telomerase activity, The EMBO J., 14, 4240-4248.
58. Chong, L., van Steensel, B., Broccoli, D., Erdjument-Bromage, H., Hanish, J., Tempst, P and de Lange, T. (1995). A human telomeric protein, Science, 270, 1663-1667